bluebird bio CEO Andrew Obenshain's 2022 pay falls 80% to $1.8M
bluebird bio reports 2022 executive compensation
By ExecPay News
Published: April 28, 2023
bluebird bio reported fiscal year 2022 executive compensation information on April 28, 2023.
In 2022, four executives at bluebird bio received on average a compensation package of $1.5M, a 68% decrease compared to previous year.
Average pay of disclosed executives at bluebird bio
Andrew Obenshain, Chief Executive Officer, received $1.8M in total, which decreased by 80% compared to 2021. 35% of Obenshain's compensation, or $643K, was in salary. Obenshain also received $386K in non-equity incentive plan, $422K in option awards, $351K in stock awards, as well as $12K in other compensation.
Jason F. Cole, Chief Strategy & Financial Officer former, received a compensation package of $1.4M, which decreased by 59% compared to previous year. 42% of the compensation package, or $606K, was in other compensation.
Richard A. Colvin, Chief Medical Officer, earned $1.4M in 2022.
Thomas J. Klima, Chief Commercial and Operating Officer, received $1.2M in 2022, which decreases by 45% compared to 2021.
Related executives
You may also like
Source: SEC filing on April 28, 2023.